Hedge Fund - Enavate Sciences
Get Email AlertsJames Boylan Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Enavate Sciences |
| Manager | James Boylan |
| Portfolio Value | $176,535,354 |
| Change This QTR | +1.33% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | IMNM | 4,768,583 | $44,347,822 | 25.12% | |||
| 2. | Sionna Therapeutics Inc | 2,478,030 | $42,993,821 | 24.35% | |||
| 3. | Zenas Biopharma Inc | 3,761,359 | $36,447,569 | 20.65% | |||
| 4. | Upstream Bio Inc | 2,459,703 | $27,007,539 | 15.3% | |||
| 5. | CMPX | 7,788,150 | $20,249,190 | 11.47% |
Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2025-09-15 | ||||
| 2025-02-18 | ||||
| 2024-10-22 | ||||
| 2024-09-23 |
Hedge Fund Resource Center 
